Mukka Proteins Acquires Remaining 2% Stake in Haris Marine Products for ₹19.64 Lakhs
Mukka Proteins Limited acquired the remaining 2% stake in Haris Marine Products Private Limited for ₹19.64 Lakhs on March 25, 2026. This consolidates their ownership to 100%. The transaction involves related parties.
The acquisition of a small percentage of a subsidiary, while positive, is unlikely to have a significant immediate impact on the overall financial performance of the parent company, hence rated as medium.
The acquisition of the remaining stake in a subsidiary is a positive development, indicating consolidation and increased control.
Mukka Proteins Limited has entered into a Share Purchase Agreement (SPA) on March 25, 2026, to acquire the remaining 2% equity share capital of Haris Marine Products Private Limited, the investee company. This acquisition follows an earlier intimation on February 12, 2026, regarding the purchase of additional shares.
The agreement is with existing shareholders Mr. Kalandan Mohammed Haris, Mr. Kalandan Mohammed Althaf, Mr. Kalandan Mohammad Arif, and Mr. Kalandan Abdul Razak. The total consideration for the acquisition of the remaining 2% equity share capital, comprising 2,000 equity shares of face value ₹100 each, is ₹19,64,000 (Nineteen Lakhs Sixty-Four Thousand Rupees).
This transaction falls under related party transactions as the promoters of Mukka Proteins Limited are also shareholders and directors of the investee company. The acquisition aims to consolidate Mukka Proteins' holding in Haris Marine Products Private Limited, increasing its ownership to 100%.
What to do with a filing like this
Mukka Proteins Limited filed this with the NSE as a statutory disclosure, categorised under acquisition. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Mukka Proteins Limited. Read the original for the full detail.